April 23, 2026 Common sweetener may trigger fat buildup in ways experts didn’t expect A new review suggests fructose has unique metabolic effects that drive obesity, fat accumulation and metabolic disease beyond what glucose alone causes.
April 20, 2026 Sen Mark Warner 'heartbroken,' announcing daughter dies of juvenile diabetes Sen. Mark Warner announces the loss of his eldest daughter Madison, 36, after a long battle with juvenile diabetes and other health problems.
April 14, 2026 Popular weight-loss medications linked to hidden side effects, study finds A new study analyzing Reddit posts found that GLP-1 users reported side effects like fatigue, chills and menstrual irregularities not seen in clinical trials.
April 10, 2026 Simple fruit combo could improve heart function in weeks, new study finds A new study found that adults with prediabetes who ate one avocado and one cup of mango daily for eight weeks saw improvements in vascular function, though experts note caveats.
April 2, 2026 New weight-loss pill hits the market, promising 'greater flexibility' FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.
April 1, 2026 Should you microdose Ozempic? Experts are split on risks vs benefits Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.
March 26, 2026 Why your sugar cravings won’t go away, even if you stop eating sweets A new study challenges the long-held belief that cutting sweet foods reduces cravings, finding no significant change in sweet tooth preferences or health markers.
March 24, 2026 New stronger weight-loss drug gets green light from FDA: 'Major jump' The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.
March 24, 2026 Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular risk by 22%, a new study finds.
March 20, 2026 Needle-free diabetes management could be on the horizon, study suggests Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a non-invasive alternative to injections.